Consistent with this view, the anti-VEGF-A monoclonal antibody bevacizumab has been approved for the treatment of several cancers, including metastatic colorectal cancer, metastatic breast cancer, and ovarian cancer [59]. The gene discussed is VEGFA; the disease is cancer.